| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |